Search results for "Neumonia"

showing 10 items of 657 documents

Italian Society of Anesthesia, Analgesia, Resuscitation, and Intensive Care expert consensus statement on the use of lung ultrasound in critically il…

2021

Abstract Background To produce statements based on the available evidence and an expert consensus (as members of the Lung Ultrasound Working Group of the Italian Society of Analgesia, Anesthesia, Resuscitation, and Intensive Care, SIAARTI) on the use of lung ultrasound for the management of patients with COVID-19 admitted to the intensive care unit. Methods A modified Delphi method was applied by a panel of anesthesiologists and intensive care physicians expert in the use of lung ultrasound in COVID-19 intensive critically ill patients to reach a consensus on ten clinical questions concerning the role of lung ultrasound in the following: COVID-19 diagnosis and monitoring (with and without i…

Mechanical ventilationmedicine.medical_specialtyResuscitationConsensusLung ultrasoundCoronavirus disease 2019business.industryLUSmedicine.medical_treatmentCOVID-19medicine.diseaseIntensive care unitlaw.inventionProne positionPneumoniaPneumothoraxlawIntensive careSettore MED/41Intensive careAnesthesiologymedicineOriginal ArticleIntensive care medicinebusinessJournal of Anesthesia, Analgesia and Critical Care
researchProduct

Off-label tocilizumab and adjuvant iron chelator effectiveness in a group of severe COVID-19 pneumonia patients

2021

ABSTRACT: Tocilizumab (TCZ), a monoclonal recombinant antibody against IL-6 receptor, is currently used in managing the cytokine release syndrome (CRS) that occurred in coronavirus disease 2019 (COVID-19) selected cases. The primary objective of our study was to establish the effectiveness of TCZ in patients with severe or critical severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pneumonia.We retrospectively analyzed 25 consecutive patients, admitted in the Academic Emergency Hospital Sibiu, Romania from April 1, 2020 until May 25, 2020, all with confirmed SARS-CoV-2 infection and severe pneumonia. All patients were treated off-label with TCZ, beside their standard care. Adjuvan…

Mechanical ventilationmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentDeferasiroxRetrospective cohort studyHydroxychloroquineGeneral Medicinemedicine.diseaseSingle Center03 medical and health sciencesCytokine release syndromechemistry.chemical_compoundPneumonia0302 clinical medicineTocilizumabchemistry030220 oncology & carcinogenesisInternal medicinemedicine030212 general & internal medicinebusinessmedicine.drugMedicine
researchProduct

Specific Features of the Coagulopathy Signature in Severe COVID-19 Pneumonia

2021

Rationale: COVID-19 displays distinct characteristics that suggest a unique pathogenesis. The objective of this study was to compare biomarkers of coagulopathy and outcomes in COVID-19 and non-COVID-19 patients with severe pneumonia.Methods: Thirty-six non-COVID-19 and 27 COVID-19 non-immunocompromised patients with severe pneumonia were prospectively enrolled, most requiring intensive care. Clinical and biological characteristics (including plasma biomarkers of coagulopathy) were compared.Results: At similar baseline severity, COVID-19 patients required mechanical ventilation (MV) for significantly longer than non-COVID-19 patients (p = 0.0049) and more frequently developed venous thrombot…

Medicine (General)medicine.medical_specialtymedicine.medical_treatmentVCAM1030204 cardiovascular system & hematologymedicine.disease_causeGastroenterologycoagulopathyPathogenesis03 medical and health sciencesR5-9200302 clinical medicineIntensive careInternal medicinemedicineCoagulopathypneumonia030212 general & internal medicinethrombosisMechanical ventilationbusiness.industryCOVID-19General MedicineImmune dysregulationBrief Research Reportacute respiratory distress syndromemedicine.diseaseThrombosisClinical trialPneumoniaMedicinebusinessFrontiers in Medicine
researchProduct

Comparative effects of carrier proteins on vaccine-induced immune response

2011

The efficacy of vaccines against major encapsulated bacterial pathogens -Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae type b (Hib) - has been significantly enhanced by conjugating the respective polysaccharides with different carrier proteins: diphtheria toxoid; non-toxic cross-reactive material of diphtheria toxin(197), tetanus toxoid, N. meningitidis outer membrane protein, and non-typeable H. influenzae-derived protein D. Hib, meningococcal, and pneumococcal conjugate vaccines have shown good safety and immunogenicity profiles regardless of the carrier protein used, although data are conflicting as to which carrier protein is the most immunogenic. Coadmini…

Meningococcal Vaccineschemical and pharmacologic phenomenamedicine.disease_causecomplex mixturesMicrobiologyPneumococcal VaccinesImmune systemAdjuvants ImmunologicConjugate vaccineStreptococcus pneumoniaemedicineHumansHaemophilus VaccinesDiphtheria toxinVaccines ConjugateGeneral VeterinaryGeneral Immunology and MicrobiologyChemistryNeisseria meningitidisImmunogenicityPolysaccharides BacterialPublic Health Environmental and Occupational HealthToxoidVaccine efficacyVirologyInfectious DiseasesMolecular MedicineCarrier ProteinsVaccine
researchProduct

Psychological support and psychotherapy via digital devices in Covid-19 emergency time: Some critical issues

2020

The Covid-19 pandemic and the resulting fear, quarantine and lockdown measures implemented in Italy and other countries to contain the risk of contagion have seriously impacted the mental health of a large number of people. The need to offer psychological and psychotherapeutic support to these people, while respecting the government’s pressing calls to “stay home”, have led many psychologists and psychotherapists, both in the public and private sectors, to provide their professional services via teleconference, telephone, smartphone, etc. The aim of this work is to highlight some critical issues related to the sudden switch from the traditional method of providing psychological services to…

Mental Health ServicesTelemedicine020205 medical informaticsPneumonia Viral02 engineering and technologye-psychological careprivacyBetacoronavirus03 medical and health sciences0302 clinical medicineInformed consent0202 electrical engineering electronic engineering information engineeringprofessional responsibilityHumansConfidentiality030212 general & internal medicinePandemicsComputer SecurityGovernmentcriticismSARS-CoV-2business.industryinformed consentTeleconferenceGeneral MedicinePublic relationsPrivate sectorProfessional responsibilityMental healthTelemedicineItalyQuarantinePsychologybusinessCovid-19Coronavirus InfectionsConfidentiality
researchProduct

Healthcare-Associated Pneumonia and Multidrug Resistant Bacteria: Do We Have a Convincing Answer?

2014

Methicillin-Resistant Staphylococcus aureusMicrobiology (medical)medicine.medical_specialtyBacteriabusiness.industryMedicine (all)Drug ResistanceBacterialPneumonia Ventilator-AssociatedBacteria; Enterobacteriaceae; Humans; Methicillin-Resistant Staphylococcus aureus; Pneumonia Ventilator-Associated; Pseudomonas aeruginosa; Drug Resistance Bacterial; Infectious Diseases; Microbiology (medical); Medicine (all)Pneumoniamedicine.diseasePneumoniaVentilator-AssociatedMultidrug resistant bacteriaInfectious DiseasesHealthcare associatedEnterobacteriaceaeDrug Resistance BacterialPseudomonas aeruginosamedicineBacteria; Enterobacteriaceae; Humans; Methicillin-Resistant Staphylococcus aureus; Pneumonia; Ventilator-Associated; Pseudomonas aeruginosa; Drug Resistance; Bacterial; Infectious Diseases; Microbiology (medical); Medicine (all)HumansIntensive care medicinebusiness
researchProduct

Cardiovascular complications in COVID-19:A systematic review and meta-analysis

2020

Microbiology (medical)2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralBioinformaticsBetacoronavirusPandemicMedicineHumansCardiovascular complicationsPandemicsinfektiotauditRetrospective Studiesbiologybusiness.industrySARS-CoV-2COVID-19Covid19komplikaatiotbiology.organism_classificationCardiovascular diseaseInfectious Diseases/dk/atira/pure/core/keywords/uob_covid19Cardiovascular DiseasesMeta-analysissydän- ja verisuonitauditbusinessCoronavirus InfectionsBetacoronavirus
researchProduct

Initial viral load and decay kinetics of SARS-CoV-2 lineage B.1.1.7 in the upper respiratory tract of adults and children

2021

We read with interest the systematic review published by Walsh et al. in the Journal of Infection,1 focusing on the dynamics of SARS-CoV-2 RNA at the upper respiratory tract (URT). In this context, a novel SARS-CoV-2 variant lineage (B.1.1.7), first detected in the UK at the end of 2020 has transmission advantage over other lineages.2 Increased transmissibility of the B.1.1.7 variant has been linked to enhanced ACE2 affinity3 allegedly resulting in higher viral loads in URT, an observation that has been reported in some,3, 4, 5, 6 but not all7 large series published to date. In addition, longer duration of SARS-CoV-2 RNA shedding in URT has been reported in individuals infected by the B.1.1…

Microbiology (medical)Adult2019-20 coronavirus outbreakLineage (genetic)Time FactorsCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralBiologySeverity of Illness IndexBetacoronavirusFecesLimit of DetectionmedicineHumansChildLetter to the EditorAsymptomatic InfectionsPandemicsNoseSARS-CoV-2SputumCOVID-19Viral LoadVirologyVirus SheddingInfectious Diseasesmedicine.anatomical_structureRNA ViralCoronavirus InfectionsViral loadRespiratory tract
researchProduct

Interstitial pulmonary inflammation due to Microbacterium sp. after heart transplantation.

2006

A coryneform bacterium was isolated from the bronchoalveolar aspirate of a patient with interstitial pulmonary inflammation. Commercial systems identified the isolate as Corynebacterium sp. or Aureobacterium sp./Corynebacterium aquaticum, but 16S rRNA gene analysis unequivocally attributed it to the genus Microbacterium. This represents the first documented case of Microbacterium pulmonary infection.

Microbiology (medical)AdultDNA BacterialMalePathologymedicine.medical_specialtySettore MED/07 - Microbiologia E Microbiologia Clinicamedicine.medical_treatmentMicrobacteriumMolecular Sequence DataInflammationMicrobiologyMicrobiologyRNA Ribosomal 16SActinomycetalesmedicineHumansPhylogenyHeart transplantationbiologyPulmonary inflammationGeneral MedicineMicrobacterium pulmonary inflammation heart transplantationPneumoniabiology.organism_classification16S ribosomal RNATransplantationCirculatory systemHeart Transplantationmedicine.symptomActinomycetales InfectionsBacteriaJournal of medical microbiology
researchProduct

Cytomegalovirus pneumonia in patients with inflammatory bowel disease: a systematic review

2012

Summary Background Inflammatory bowel disease (IBD) patients are at increased risk of cytomegalovirus (CMV) reactivation, and although CMV pneumonia may be a fatal disease in IBD patients, little information is available on this issue. The objectives of this study were to identify risk factors for the development of CMV pneumonia in IBD patients and to find useful information to better manage this potentially fatal complication. Methods A computerized search without language restrictions was conducted using PubMed and SCOPUS. An article was considered eligible for inclusion in the systematic review if it reported detailed data on patients with IBD presenting with pneumonia due to CMV. Resul…

Microbiology (medical)AdultMalePediatricsmedicine.medical_specialtyPneumonia ViralCongenital cytomegalovirus infectionCytomegalovirusHemophagocytic lymphohistiocytosisTachypneaInflammatory bowel diseaseInflammatory bowel diseaseRisk FactorsIntensive caremedicineHumanspneumoniapneumonia; Inflammatory bowel disease; CytomegalovirusCrohn's diseasesHemophagocytic lymphohistiocytosisbusiness.industryGeneral Medicinemedicine.diseaseInflammatory Bowel DiseasesUlcerative colitisSurgeryPneumoniaInfectious DiseasesUlcerative colitisCytomegalovirus InfectionsFemaleVirus Activationmedicine.symptomComplicationbusiness
researchProduct